Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-16 Sale |
2022-08-18 5:36 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Director |
5,000 | $9.8061 | $49,031 | 11,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-07-03 Option Award |
2023-07-06 5:37 pm |
N/A 2033-07-02 |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David CEO |
750,000 | $0 | 750,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 9:12 pm |
N/A 2033-01-31 |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Interim CEO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Director |
18,000 | $0 | 28,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 7:22 pm |
N/A 2031-03-11 |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Director |
15,000 | $0 | 20,000 (Direct) |
View |